0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Artificial Blood Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-8O10553
Home | Market Reports | Health| Pharmacy
Global Artificial Blood Products Market Insights Forecast to 2028
BUY CHAPTERS

Artificial Blood Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-8O10553
Report
November 2024
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Artificial Blood Products - Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Artificial Blood Products - Market

Artificial Blood Products - Market

The global market for Artificial Blood Products was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Artificial Blood Products, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Artificial Blood Products by region & country, by Type, and by Application.
The Artificial Blood Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood Products.
Market Segmentation

Scope of Artificial Blood Products - Market Report

Report Metric Details
Report Name Artificial Blood Products - Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type:
  • Perfluorocarbon-based Oxygen Carrier (PFBOC)
  • Hemoglobin-based Oxygen Carrier (HBOC)
Segment by Application
  • Military
  • Civil
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aurum Biosciences Ltd., HEMARINA SA, HbO2 Therapeutics, KaloCyte Inc., SpheriTech Ltd., NuvOx Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Artificial Blood Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Artificial Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Artificial Blood Products in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Artificial Blood Products - Market report?

Ans: The main players in the Artificial Blood Products - Market are Aurum Biosciences Ltd., HEMARINA SA, HbO2 Therapeutics, KaloCyte Inc., SpheriTech Ltd., NuvOx Pharma

What are the Application segmentation covered in the Artificial Blood Products - Market report?

Ans: The Applications covered in the Artificial Blood Products - Market report are Military, Civil

What are the Type segmentation covered in the Artificial Blood Products - Market report?

Ans: The Types covered in the Artificial Blood Products - Market report are Perfluorocarbon-based Oxygen Carrier (PFBOC), Hemoglobin-based Oxygen Carrier (HBOC)

1 Market Overview
1.1 Artificial Blood Products Product Introduction
1.2 Global Artificial Blood Products Market Size Forecast
1.2.1 Global Artificial Blood Products Sales Value (2019-2030)
1.2.2 Global Artificial Blood Products Sales Volume (2019-2030)
1.2.3 Global Artificial Blood Products Sales Price (2019-2030)
1.3 Artificial Blood Products Market Trends & Drivers
1.3.1 Artificial Blood Products Industry Trends
1.3.2 Artificial Blood Products Market Drivers & Opportunity
1.3.3 Artificial Blood Products Market Challenges
1.3.4 Artificial Blood Products Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Blood Products Players Revenue Ranking (2023)
2.2 Global Artificial Blood Products Revenue by Company (2019-2024)
2.3 Global Artificial Blood Products Players Sales Volume Ranking (2023)
2.4 Global Artificial Blood Products Sales Volume by Company Players (2019-2024)
2.5 Global Artificial Blood Products Average Price by Company (2019-2024)
2.6 Key Manufacturers Artificial Blood Products Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Artificial Blood Products Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Artificial Blood Products
2.9 Artificial Blood Products Market Competitive Analysis
2.9.1 Artificial Blood Products Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Artificial Blood Products Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Products as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Perfluorocarbon-based Oxygen Carrier (PFBOC)
3.1.2 Hemoglobin-based Oxygen Carrier (HBOC)
3.2 Global Artificial Blood Products Sales Value by Type
3.2.1 Global Artificial Blood Products Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Artificial Blood Products Sales Value, by Type (2019-2030)
3.2.3 Global Artificial Blood Products Sales Value, by Type (%) (2019-2030)
3.3 Global Artificial Blood Products Sales Volume by Type
3.3.1 Global Artificial Blood Products Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Artificial Blood Products Sales Volume, by Type (2019-2030)
3.3.3 Global Artificial Blood Products Sales Volume, by Type (%) (2019-2030)
3.4 Global Artificial Blood Products Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Military
4.1.2 Civil
4.2 Global Artificial Blood Products Sales Value by Application
4.2.1 Global Artificial Blood Products Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Artificial Blood Products Sales Value, by Application (2019-2030)
4.2.3 Global Artificial Blood Products Sales Value, by Application (%) (2019-2030)
4.3 Global Artificial Blood Products Sales Volume by Application
4.3.1 Global Artificial Blood Products Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Artificial Blood Products Sales Volume, by Application (2019-2030)
4.3.3 Global Artificial Blood Products Sales Volume, by Application (%) (2019-2030)
4.4 Global Artificial Blood Products Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Artificial Blood Products Sales Value by Region
5.1.1 Global Artificial Blood Products Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Artificial Blood Products Sales Value by Region (2019-2024)
5.1.3 Global Artificial Blood Products Sales Value by Region (2025-2030)
5.1.4 Global Artificial Blood Products Sales Value by Region (%), (2019-2030)
5.2 Global Artificial Blood Products Sales Volume by Region
5.2.1 Global Artificial Blood Products Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Artificial Blood Products Sales Volume by Region (2019-2024)
5.2.3 Global Artificial Blood Products Sales Volume by Region (2025-2030)
5.2.4 Global Artificial Blood Products Sales Volume by Region (%), (2019-2030)
5.3 Global Artificial Blood Products Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Artificial Blood Products Sales Value, 2019-2030
5.4.2 North America Artificial Blood Products Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Artificial Blood Products Sales Value, 2019-2030
5.5.2 Europe Artificial Blood Products Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Artificial Blood Products Sales Value, 2019-2030
5.6.2 Asia Pacific Artificial Blood Products Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Artificial Blood Products Sales Value, 2019-2030
5.7.2 South America Artificial Blood Products Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Artificial Blood Products Sales Value, 2019-2030
5.8.2 Middle East & Africa Artificial Blood Products Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Blood Products Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Artificial Blood Products Sales Value
6.2.1 Key Countries/Regions Artificial Blood Products Sales Value, 2019-2030
6.2.2 Key Countries/Regions Artificial Blood Products Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Artificial Blood Products Sales Value, 2019-2030
6.3.2 United States Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Artificial Blood Products Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Artificial Blood Products Sales Value, 2019-2030
6.4.2 Europe Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Artificial Blood Products Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Artificial Blood Products Sales Value, 2019-2030
6.5.2 China Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
6.5.3 China Artificial Blood Products Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Artificial Blood Products Sales Value, 2019-2030
6.6.2 Japan Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Artificial Blood Products Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Artificial Blood Products Sales Value, 2019-2030
6.7.2 South Korea Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Artificial Blood Products Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Blood Products Sales Value, 2019-2030
6.8.2 Southeast Asia Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Artificial Blood Products Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Artificial Blood Products Sales Value, 2019-2030
6.9.2 India Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
6.9.3 India Artificial Blood Products Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Aurum Biosciences Ltd.
7.1.1 Aurum Biosciences Ltd. Company Information
7.1.2 Aurum Biosciences Ltd. Introduction and Business Overview
7.1.3 Aurum Biosciences Ltd. Artificial Blood Products Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Aurum Biosciences Ltd. Artificial Blood Products Product Offerings
7.1.5 Aurum Biosciences Ltd. Recent Development
7.2 HEMARINA SA
7.2.1 HEMARINA SA Company Information
7.2.2 HEMARINA SA Introduction and Business Overview
7.2.3 HEMARINA SA Artificial Blood Products Sales, Revenue and Gross Margin (2019-2024)
7.2.4 HEMARINA SA Artificial Blood Products Product Offerings
7.2.5 HEMARINA SA Recent Development
7.3 HbO2 Therapeutics
7.3.1 HbO2 Therapeutics Company Information
7.3.2 HbO2 Therapeutics Introduction and Business Overview
7.3.3 HbO2 Therapeutics Artificial Blood Products Sales, Revenue and Gross Margin (2019-2024)
7.3.4 HbO2 Therapeutics Artificial Blood Products Product Offerings
7.3.5 HbO2 Therapeutics Recent Development
7.4 KaloCyte Inc.
7.4.1 KaloCyte Inc. Company Information
7.4.2 KaloCyte Inc. Introduction and Business Overview
7.4.3 KaloCyte Inc. Artificial Blood Products Sales, Revenue and Gross Margin (2019-2024)
7.4.4 KaloCyte Inc. Artificial Blood Products Product Offerings
7.4.5 KaloCyte Inc. Recent Development
7.5 SpheriTech Ltd.
7.5.1 SpheriTech Ltd. Company Information
7.5.2 SpheriTech Ltd. Introduction and Business Overview
7.5.3 SpheriTech Ltd. Artificial Blood Products Sales, Revenue and Gross Margin (2019-2024)
7.5.4 SpheriTech Ltd. Artificial Blood Products Product Offerings
7.5.5 SpheriTech Ltd. Recent Development
7.6 NuvOx Pharma
7.6.1 NuvOx Pharma Company Information
7.6.2 NuvOx Pharma Introduction and Business Overview
7.6.3 NuvOx Pharma Artificial Blood Products Sales, Revenue and Gross Margin (2019-2024)
7.6.4 NuvOx Pharma Artificial Blood Products Product Offerings
7.6.5 NuvOx Pharma Recent Development
8 Industry Chain Analysis
8.1 Artificial Blood Products Industrial Chain
8.2 Artificial Blood Products Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Artificial Blood Products Sales Model
8.5.2 Sales Channel
8.5.3 Artificial Blood Products Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Artificial Blood Products Market Trends
    Table 2. Artificial Blood Products Market Drivers & Opportunity
    Table 3. Artificial Blood Products Market Challenges
    Table 4. Artificial Blood Products Market Restraints
    Table 5. Global Artificial Blood Products Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Artificial Blood Products Revenue Market Share by Company (2019-2024)
    Table 7. Global Artificial Blood Products Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Artificial Blood Products Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Artificial Blood Products Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Artificial Blood Products Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Artificial Blood Products Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Artificial Blood Products
    Table 13. Global Artificial Blood Products Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Products as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Artificial Blood Products Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Artificial Blood Products Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Artificial Blood Products Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Artificial Blood Products Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Artificial Blood Products Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Artificial Blood Products Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Artificial Blood Products Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Artificial Blood Products Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Artificial Blood Products Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Artificial Blood Products Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Artificial Blood Products Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Artificial Blood Products Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Artificial Blood Products Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Artificial Blood Products Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Artificial Blood Products Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Artificial Blood Products Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Artificial Blood Products Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Artificial Blood Products Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Artificial Blood Products Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Artificial Blood Products Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Artificial Blood Products Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Artificial Blood Products Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Artificial Blood Products Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Artificial Blood Products Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Artificial Blood Products Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Artificial Blood Products Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Artificial Blood Products Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Artificial Blood Products Sales Value by Region (2019-2024) & (%)
    Table 44. Global Artificial Blood Products Sales Value by Region (2025-2030) & (%)
    Table 45. Global Artificial Blood Products Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Artificial Blood Products Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Artificial Blood Products Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Artificial Blood Products Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Artificial Blood Products Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Artificial Blood Products Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Artificial Blood Products Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Artificial Blood Products Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Artificial Blood Products Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Artificial Blood Products Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Artificial Blood Products Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Artificial Blood Products Sales Volume, (2025-2030) & (K Units)
    Table 57. Aurum Biosciences Ltd. Company Information
    Table 58. Aurum Biosciences Ltd. Introduction and Business Overview
    Table 59. Aurum Biosciences Ltd. Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Aurum Biosciences Ltd. Artificial Blood Products Product Offerings
    Table 61. Aurum Biosciences Ltd. Recent Development
    Table 62. HEMARINA SA Company Information
    Table 63. HEMARINA SA Introduction and Business Overview
    Table 64. HEMARINA SA Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. HEMARINA SA Artificial Blood Products Product Offerings
    Table 66. HEMARINA SA Recent Development
    Table 67. HbO2 Therapeutics Company Information
    Table 68. HbO2 Therapeutics Introduction and Business Overview
    Table 69. HbO2 Therapeutics Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. HbO2 Therapeutics Artificial Blood Products Product Offerings
    Table 71. HbO2 Therapeutics Recent Development
    Table 72. KaloCyte Inc. Company Information
    Table 73. KaloCyte Inc. Introduction and Business Overview
    Table 74. KaloCyte Inc. Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. KaloCyte Inc. Artificial Blood Products Product Offerings
    Table 76. KaloCyte Inc. Recent Development
    Table 77. SpheriTech Ltd. Company Information
    Table 78. SpheriTech Ltd. Introduction and Business Overview
    Table 79. SpheriTech Ltd. Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. SpheriTech Ltd. Artificial Blood Products Product Offerings
    Table 81. SpheriTech Ltd. Recent Development
    Table 82. NuvOx Pharma Company Information
    Table 83. NuvOx Pharma Introduction and Business Overview
    Table 84. NuvOx Pharma Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. NuvOx Pharma Artificial Blood Products Product Offerings
    Table 86. NuvOx Pharma Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Artificial Blood Products Downstream Customers
    Table 90. Artificial Blood Products Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Artificial Blood Products Product Picture
    Figure 2. Global Artificial Blood Products Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Artificial Blood Products Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Artificial Blood Products Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Artificial Blood Products Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Artificial Blood Products Report Years Considered
    Figure 7. Global Artificial Blood Products Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Artificial Blood Products Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Artificial Blood Products Revenue in 2023
    Figure 10. Artificial Blood Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Perfluorocarbon-based Oxygen Carrier (PFBOC) Picture
    Figure 12. Hemoglobin-based Oxygen Carrier (HBOC) Picture
    Figure 13. Global Artificial Blood Products Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Artificial Blood Products Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Artificial Blood Products Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Artificial Blood Products Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Artificial Blood Products Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Military
    Figure 19. Product Picture of Civil
    Figure 20. Global Artificial Blood Products Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Artificial Blood Products Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Artificial Blood Products Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Artificial Blood Products Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Artificial Blood Products Price by Application (2019-2030) & (US$/Unit)
    Figure 25. North America Artificial Blood Products Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Artificial Blood Products Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Artificial Blood Products Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Artificial Blood Products Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Artificial Blood Products Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Artificial Blood Products Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Artificial Blood Products Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Artificial Blood Products Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Artificial Blood Products Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Artificial Blood Products Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Artificial Blood Products Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Artificial Blood Products Sales Volume (%), (2019-2030)
    Figure 37. United States Artificial Blood Products Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Artificial Blood Products Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Artificial Blood Products Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Artificial Blood Products Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Artificial Blood Products Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Artificial Blood Products Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Artificial Blood Products Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Artificial Blood Products Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Artificial Blood Products Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Artificial Blood Products Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Artificial Blood Products Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Artificial Blood Products Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Artificial Blood Products Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Artificial Blood Products Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Artificial Blood Products Sales Value by Application (%), 2023 VS 2030
    Figure 58. Artificial Blood Products Industrial Chain
    Figure 59. Artificial Blood Products Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global Ibuprofen Sodium​ API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30X13296
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Enteric Gelatin Hollow Capsule Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11U13426
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Argatroban Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-16160
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-10G2665
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

OSZAR »